Your browser doesn't support javascript.
loading
COVID-19 in 3 patients treated with immune checkpoint inhibitors for advanced melanoma.
Arenbergerova, M; Gkalpakiotis, S; Arenberger, P; Fialova, A; Pasek, M.
Affiliation
  • Arenbergerova M; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Gkalpakiotis S; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Arenberger P; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Fialova A; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
  • Pasek M; Department of Dermatovenereology, Third Faculty of Medicine, Charles University and Kralovske Vinohrady University Hospital, Prague, Czech Republic.
J Dermatolog Treat ; 33(3): 1782-1783, 2022 05.
Article in En | MEDLINE | ID: mdl-33092421
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Skin Neoplasms / COVID-19 / Melanoma Limits: Humans Language: En Journal: J Dermatolog Treat Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Skin Neoplasms / COVID-19 / Melanoma Limits: Humans Language: En Journal: J Dermatolog Treat Year: 2022 Document type: Article